A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

Cystic fibrosis causes a buildup of mucus in the lungs that can lead to infection, and often death in children and young ...

Multiple breath washout was done in 10% of Europeans with cystic fibrosis in 2023, mostly in children and in adults with near ...

Animate Biosciences today announces positive preclinical results from a mouse model of pulmonary fibrosis demonstrating that ...

This trial marks the first time that automated, quantitative high-resolution CT (HRCT) imaging biomarkers will serve as a ...

Pulmonary fibrosis significantly impacts sexual function, with 74% of patients experiencing dyspnea during sexual activity, affecting their quality of life. The study used UCSD-SOBQ and SPARC ...

Presence of cardiac fibrosis puts high-level endurance athletes at increased risk for ventricular tachycardia while exercising ...

The global pulmonary fibrosis market is witnessing robust growth, driven by the rising prevalence of idiopathic pulmonary fibrosis (IPF) and interstitial lung diseases, largely due to an aging ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

Sigachi Industries introduces a new Cystic Fibrosis API combination, enhancing its strategic focus on complex specialty ...